Profile
The South East Asia Infectious Disease Clinical Research Network (SEAICRN) is a collaborative partnership between hospitals and research institutions within Thailand, Viet Nam and Indonesia, the National Institutes of Allergy and Infectious Diseases (USA) and the Wellcome Trust (UK) that was first formed in September 2005.
The Network was created in order to develop the necessary partnerships in South East Asia to (i) conduct collaborative clinical research that addresses emerging threats, (ii) increase evidence-based scientific knowledge and (iii) improve the clinical management of patients with infectious diseases of public health importance.
Technical leadership is provided by the SEAICRN Executive Committee which includes members from all Network countries and partners
The World Health Organization (WHO) participates in the SEAICRN as an observer.
The SEAICRN's Main Goals
The SEAICRN strives to advance the scientific knowledge and clinical management of infectious diseases in South East Asia through collaborative clinical research. The scientific output of the SEAICRN seeks to provide policy makers across the region with evidence-based data to support changes in public health policy and guidelines. Furthermore, the SEAICRN endeavours to boost the research capacity of participating institutions and individuals within the Network.
The SEAICRN's Main Values
The Network's core values define it's character and forms the foundation on which we perform our work and conduct ourselves.
Mutual respect
Scientific and ethical integrity
Transparency
Commitment
The SEAICRN's Funding
The SEAICRN is funded by:
-
The US National Institutes of Health’s National Institute of Allergy and Infectious Diseases, US
-
In-kind support from the Governments of Thailand, Viet Nam and Indonesia
Funding bodies also provide scientific support and guidance to the activities of the SEAICRN.
Others interested in supporting the SEAICRN's research activities may contact nccinfo@eocru.org for further information.